Equally contributed to this paper.
CD14+ cell–derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation
Version of Record online: 19 AUG 2010
© 2010 John Wiley & Sons A/S
Volume 66, Issue 2, pages 238–246, February 2011
How to Cite
He, S., Li, T., Chen, H., Ma, W., Yao, Q., Yang, H., Wang, H., Wang, F., Zhao, C. and Yang, P. (2011), CD14+ cell–derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation. Allergy, 66: 238–246. doi: 10.1111/j.1398-9995.2010.02455.x
Edited by: Hans-Uwe Simon
- Issue online: 5 JAN 2011
- Version of Record online: 19 AUG 2010
- Accepted for publication 28 June 2010
Figure S1. Gene silence of IL-29 receptor (IL-10R2).
Figure S2. CD4+ T-cells proliferation.
Figure S3. Control siRNA of IL-29R does not affect CD4+ T cells to produce IL-6 and tumor necrosis factor (TNF)-α.
Figure S4. CD4+ T cells express IL-29 receptor.
Table S1. Asthmatic patient demographics and clinical characteristics.
|ALL_2455_sm_FigS1-4-TableS1.doc||172K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.